Statistically speaking a larger sample size means they can theoretically achieve a positive result (i.e. statistically significant improvements) even if the results are not as good as the Phase 2 trial. i.e. a smaller improvement could still be statistically valid (p<0.05) in this trial, even though it might not have been valid for the Phase 2 trial.
Share Price, page-146
-
- There are more pages in this discussion • 11,925 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.09 |
Change
-0.185(1.21%) |
Mkt cap ! $1.921B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.47 | $14.93 | $3.675M | 243.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 567 | $15.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.09 | 361 | 19 |
View Market Depth
| Last trade - 13.45pm 30/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |